Page 99 - Read Online

Sulaiman et al. J Transl Genet Genom 2020;4:159-87 I https://doi.org/10.20517/jtgg.2020.27 Page 185

160. Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell
2006;126:107-20.
161. Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, et al. Glycolytic enzymes can modulate cellular life Span. Cancer Res 2005;65:177-85.
162. Zhou S, Kachhap S, Singh KK. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 2003;18:287-92.
163. Lebedeva MA, Eaton JS, Shadel GS. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species
homeostasis. Biochim Biophys Acta 2009;1787:328-34.
164. Kulawiec M, Ayyasamy V, Singh KK. p53 regulates mtDNA copy number and mitocheckpoint pathway. J carcinog 2009;8:8.
165. D’Souza AD, Parikh N, Kaech SM, Shadel GS. Convergence of multiple signaling pathways is required to coordinately up-regulate
mtDNA and mitochondrial biogenesis during T cell activation. Mitochondrion 2007;7:374-85.
166. Di Donato S. Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration. J Inherit Metab
Dis 2000;23:247-63.
167. Polster BM, Fiskum G. Mitochondrial mechanisms of neural cell apoptosis. J Neurochem 2004;90:1281-9.
168. Rehm M, Düßmann H, Jänicke RU, Tavaré JM, Kögel D, et al. Single-cell fluorescence resonance energy transfer analysis demonstrates
that caspase activation during apoptosis is a rapid process: role of caspase-3. J Biol Chem 2002;277:24506-14.
169. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, et al. Identification of DIABLO, a mammalian protein that promotes
apoptosis by binding to and antagonizing IAP proteins. Cell 2000;102:43-53.
170. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and
cytochrome c. Cell 1996;86:147-57.
171. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, et al. Molecular characterization of mitochondrial apoptosis-inducing factor.
Nature 1999;397:441-6.
172. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by
eliminating IAP inhibition. Cell 2000;102:33-42.
173. Zou H, Li Y, Liu X, Wang X. An APAF-1·Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J
Biolog Chem 1999;274:11549-56.
174. Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007;145:1233-
48.
175. Saccon RA, Bunton-Stasyshyn RKA, Fisher EMC, Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Brain: a
journal of neurology 2013;136:2342-58.
176. Grünewald A, Kumar KR, Sue CM. New insights into the complex role of mitochondria in Parkinson’s disease. Prog Neurobiol
2019;177:73-93.
177. Antony PMA, Kondratyeva O, Mommaerts K, Ostaszewski M, Sokolowska K, et al. Fibroblast mitochondria in idiopathic Parkinson’s
disease display morphological changes and enhanced resistance to depolarization. Sci Rep 2020;10:1569.
178. Sironi L, Restelli LM, Tolnay M, Neutzner A, Frank S. Dysregulated Interorganellar Crosstalk Of Mitochondria In The Pathogenesis of
Parkinson’s disease. Cells 2020;9:233.
179. Suomalainen A, Battersby BJ. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol
2018;19:77-92.
180. Rahman J, Rahman S. Mitochondrial medicine in the omics era. Lancet 2018;391:2560-74.
181. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature
1988;331:717-9.
182. Ingman M, Gyllensten U. mtDB: Human mitochondrial genome database, a resource for population genetics and medical sciences.
Nucleic Acids Res 2006;34:D749-51.
183. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, et al. Mutation of a nuclear succinate dehydrogenase gene results in
mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-9.
184. Ye F, Samuels DC, Clark T, Guo Y. High-throughput sequencing in mitochondrial DNA research. Mitochondrion 2014;17:157-63.
185. Liang MH, Johnson DR, Wong LJC. Preparation and validation of PCR-generated positive controls for diagnostic dot blotting. Clin Chem
1998;44:1578-9.
186. Bai RK, Wong LJC. Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory
mutation system quantitative PCR analysis: a single-step approach. Clin Chem 2004;50:996-1001.
187. White HE, Durston VJ, Seller A, Fratter C, Harvey JF, et al. Accurate detection and quantitation of heteroplasmic mitochondrial point
mutations by pyrosequencing. Genet Test 2005;9:190-9.
188. Pronicka E, Piekutowska-Abramczuk D, Ciara E, Trubicka J, Rokicki D, et al. New perspective in diagnostics of mitochondrial disorders:
two years’ experience with whole-exome sequencing at a national paediatric centre. J Transl Med 2016;14:174.
189. Kohda M, Tokuzawa Y, Kishita Y, Nyuzuki H, Moriyama Y, et al. A comprehensive genomic analysis reveals the genetic landscape of
mitochondrial respiratory chain complex deficiencies. PLoS Genet 2016;12:e1005679.
190. Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, et al. Molecular diagnosis of infantile mitochondrial disease with targeted
next-generation sequencing. Sci Transl Med 2012;4:118ra10.
191. Gould MP, Bosworth CM, McMahon S, Grandhi S, Grimberg BT, et al. PCR-free enrichment of mitochondrial DNA from human blood
and cell lines for high quality next-generation DNA sequencing. PLoS One 2015;10:e0139253.
192. Vasta V, Ng SB, Turner EH, Shendure J, Hahn SH. Next generation sequence analysis for mitochondrial disorders. Genome Med
2009;1:100.